<DOC>
	<DOCNO>NCT00647777</DOCNO>
	<brief_summary>The objective study investigate bioequivalence Mylan olanzapine 5 mg tablet Eli Lilly 's Zyprexa® 5 mg tablet follow single , oral 5 mg ( 1 x 5 mg ) dose administer fed condition .</brief_summary>
	<brief_title>Food Study Olanzapine Tablets 5 mg Zyprexa® Tablets 5 mg</brief_title>
	<detailed_description />
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Age : 18 year old . 2 . Sex : Male nonpregnant , nonlactating female 1 . Women childbearing potential must negative serum ( Beta HCG ) pregnancy test perform within 14 day prior start study even prior dose administration . If dose schedule Sunday Monday , HCG pregnancy test give within 48 hour prior dose study period . An additional serum ( Beta HCG ) pregnancy test perform upon completion study . 2 . Women childbearing potential must practice abstinence use acceptable form contraception throughout duration study . No hormonal contraceptive hormonal replacement therapy permit study . Acceptable form contraception include follow : 1. intrauterine device place least 3 month prior start study remain place study period , 2. barrier method contain use conjunction spermicidal agent , 3. surgical sterility ( tubal ligation , oophorectomy hysterectomy ) postmenopausal accompany document postmenopausal course least one year . 3 . During course study , study screen study exit include washout period , woman childbearing potential must use spermicide contain barrier method contraception addition current contraceptive device . This advice document informed consent form . 3 . Weight : At least 60 kg ( 132 lb ) man 48 kg ( 106 lb ) woman within 15 % Ideal Body Weight ( IBW ) , reference Table `` '' Desirable Weights Adults '' '' Metropolitan Life Insurance Company , 1999 ( See Part II ADMINISTRATIVE ASPECTS OF BIOEQUIVALENCE PROTOCOLS ) . 4 . All subject judge normal healthy prestudy medical evaluation ( physical examination , laboratory evaluation , 12lead ECG , hepatitis B hepatitis C test , HIV test , urine drug screen include amphetamine , barbiturate , benzodiazepine , cannabinoid , cocaine , opiates , phencyclidine , methadone ) perform within 14 day initial dose study medication '' 1 . Institutionalized subject use . 2 . Social Habits : 1 . Use tobacco product . 2 . Ingestion alcoholic , caffeine xanthinecontaining food beverage within 48 hour prior initial dose study medication . 3 . Ingestion vitamins herbal product within 48 hour prior initial dose study medication . 4 . Any recent , significant change dietary exercise habit 3 . Medications : 1 . Use medication within 14 day prior initial dose study medication . 2 . Use medication know alter hepatic enzyme activity within 28 day prior initial dose study medication . 3 . Use hormonal contraceptive hormonal replacement therapy within three month prior initial dose study medication . 4 . Diseases : 1 . History significant chronic disease and/or hepatitis . 2 . History drug and/or alcohol abuse . 3 . Acute illness time either prestudy medical evaluation dosing . 4 . Positive HIV , Hepatitis B , Hepatitis C test . 5 . Abnormal clinically significant laboratory test result : 1 . Clinically significant deviation Guide Clinically Relevant Abnormalities ( See Part II ADMINISTRATIVE ASPECTS OF BIOEQUIVALENCE PROTOCOLS ) . 2 . Abnormal clinically relevant ECG tracing . 6 . Sitting heart rate le 60 beat per minute sit systolic blood pressure le 110 great 140 sit diastolic blood pressure less great 90 fiveminute rest period Screening sit heart rate le 60 beat per minute sit systolic blood pressure le 100 great 140 sit diastolic blood pressure le 60 great 90 fiveminute rest period prior dose . 7 . Donation loss significant volume blood plasma ( &gt; 450 mL ) within 28 day prior initial dose study medication . 8 . Subjects receive investigational drug within 30 day prior initial dose study medication . 9 . Allergy hypersensitivity olanzapine , inactive ingredient , related product . 10 . History difficulty swallow , gastrointestinal disease could affect drug absorption . 11 . Consumption grapefruit grapefruit containing product within 7 day drug administration ''</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>